TranXenoGen, Inc. has signed a collaborative agreement with Abbott Laboratories to evaluate TranXenoGen’s avian transgenic technology for production of a monoclonal antibody under development at the Abbott Bioresearch Center. The TranXenoGen avian transgenic technology allows for the expression of gene encoding of proteins from cells. As a result, the technology can be used for high-volume Read more about Tranxenogen Announces Collaboration With Abbott[…]